VTF-All /PGS Effect : LBR / cycle / 1st ET

Slides:



Advertisements
Similar presentations
Is Frozen Embryo Transfer better than Fresh?
Advertisements

PREVENTION OF MULTIPLES FROM A CLINICIAN’S STANDPOINT Bulent Urman M.D. American Hospital of Istanbul.
Public Reporting of ART Outcomes Kevin Doody MD
But it still needs a bit of work. Reprogenetics ART Institute of Washington Life Global Principle investigator of cytoplasmic transfer.
“Octomom”: Ethical Problems in the Nadya Suleman Case Jan Hare, Ph.D. Human Development and Family Studies Dept.
The Opportunity . Of this, IVF contributes to 70 per cent, IUI to 22 per cent, and surrogacy to 7 per cent. Size of Indian IVF market is estimated at.
In Vitro Fertilisation (IVF) IVF enables fertilisation, outside the body, in a culture dish.
IVM is ready as a treatment for PCOS patients
The outcome of oocyte freezing as compared with embryo freezing Filippo Maria Ubaldi M.D. M.Sc. CLINICA VALLE GIULIA, Rome 3° Congress of Society of Reproductive.
07:091 Clinical experience of PB biopsy and CGH micro-array in poor prognosis IVF patients Stuart Lavery Stuart Lavery Consultant Gynaecologist Director.
Selective Single Embryo Transfers: A Preliminary Study L. Keith Smith, Ellen H. Roots and M. Janelle Odom Dorsett The Centre for Reproductive Medicine,
New England Fertility Institute Lifeline Cryogenics Gad Lavy, M.D., F.A.C.O.G. Life begins here…
AT THE FOREFRONT OF SINGLE CELL GENETIC ANALYSIS.
IVF and PGD. In Vitro Fertilization  First test tube baby – Louise Brown  According to CDC’s 2010 ART Success Rates, 147,260* ART cycles were.
Veronica Bianchi declares no conflict of interest.
Suzanne Hodgson Researcher in Statistics & Epidemiology SCAAC – 12 June 2013 Updated Blastocyst Analysis.
Altered Sex Ratio and Increased Monozygotic Twinning Following Day 6 Blastocyst Transfers in Human IVF-ET Ellen H. Roots, L. Keith Smith and M. Janelle.
In vitro fertilisation (I.V.F)
KED - Society of Clinical Embryologists 1 st Symposium, Istanbul Alan Thornhill The Bridge Centre, London, UK December 5 th 2012 Assessment of Gamete/Embryo.
Aline de Cássia Azevedo (a,b) ; Fernanda Coimbra Miyasato (b) ; Litsuko S. Fujihara (b), Maria Cecília R.M. Albuquerque (b), Ticiana V. Oliveira (b), Luiz.
Results 13 papers Heterogeneity of morphokinetic and conditions (culture media, mode of fertilization, day of ET)
In Vitro Fertilisation (IVF) IVF enables fertilisation, outside the body, in a culture dish.
A Unified Approach to Human Embryo Culture
QUALITY CONTROL IN THE IVF LAB.
Assisted Reproductive Technology (ART) Adapted from Mary L. Davenport, M.D. (UCLA at Berkeley), 2009.
Topic- Test Tube Baby Group members: Mohd. Hasnanin Nizam Thakur Rifaquat Ahmed Rafiul Islam Adib Course Teacher: Dr. Aparna Islam Associate Professor.
 What if you could screen embryos for diseases before they became babies?  What if you could choose the traits your baby would have?  Would you use.
 Generally in the ivf procedure, the sperm and the egg are kept for fertilization inside the body of a woman. When the fertilized egg is attached to the.
Fertility First Specialised fertility care for men and women.
Risks of treatment Research projects
Low Cost IVF Treatment With Myra IVF India Why IVF Treatment? IVF can be done in the following situations: Blockage in fallopian tube due to which it is.
Success rates.
In The Name Of God. In The Name Of God Prenatal Diagnosis of Congenital Disorders Dr. Gita Hatamizadeh OBGYN- Infertility Fellowship Assisted professor.
Too slow? we don’t think so. Outcomes relative to embryo development
Human Genetic Engineering
IVF Treatment Create your Future through IVF Treatment
The bank of embryo and the process of embryo Cryopreservation
Table 2. RCTs analyzed illustrating SET superiority over DET
IVF Clinic in Mumbai.
Pregnancy outcomes after assisted reproductive procedures of embryos derived from affected and unaffected ovaries among women with small unilateral endometriomas.
HOW MANY DOES IT TAKE? ACHIEVEMENT OF EUPLOID BLASTOCYST (BL) AS THE PRIMARY PREDICTOR OF LIVE BIRTH (LB) IN OOCYTE CRYOPRESERVATION (OC) Shannon DeVore.
Preimplantation Genetic Diagnosis (PGD)
BLASTOCYST VITRIFICATION and PREIMPLANTATION GENETIC SCREENING (PGS) HAVE FACILITATED “FREEZE-ALL” CYCLES: A CHANGE IN PRACTICE MANAGEMENT BENEFITTING.
A HURDLE IN THE EGG FREEZING RACE: COMPARISON OF DONOR AND AUTOLOGOUS OOCYTE CRYOPRESERVATION OUTCOMES NYU Langone Fertility Center Sarah Druckenmiller,
Put on ice twice: a problem
The effect of the duration of stimulation on ART outcomes
ROUTINE TRANSFER OF MULTIPLE EMBRYOS IS NO LONGER NECESSARY TO ACHIEVE HIGH RATES OF HEALTHY SINGLETON BIRTHS PER TRANSFER IN WOMEN UP TO 42 YEARS OLD.
Can we further reduce multiple pregnancies in Belgium?
N.I Sesina*, V.R. Aleksandrova, K.V. Krasnopolskaya
Mitchel C Schiewe, PhD, HCLD
Recurrent IVF failure: other factors
Understanding IVF Processes in Surrogacy
Fertility Center A HURDLE IN THE EGG FREEZING RACE: COMPARISON OF DONOR AND AUTOLOGOUS OOCYTE CRYOPRESERVATION (OC) OUTCOMES Sarah Druckenmiller, Patty.
Increasing Demand for Fertility Treatments
Blastocyst versus cleaved embryo transfer: do we have enough evidence?
Effects of maternal age on euploidy rates in a large cohort of embryos analyzed with 24- chromosome single-nucleotide polymorphism–based preimplantation.
Mid-luteal serum progesterone concentrations govern implantation rates for cryopreserved embryo transfers conducted under hormone replacement  John L.
CV - Dr. Suresh Kattera, Singapore
A. Pujol, MJ. Zamora, A. Obradors, D. Garcia,
Progress we can be proud of: U. S
CV - Dr. Suresh Kattera, Singapore
IMPLANTATION & IVF SUCCESS
APPLICATION OF VITRIFICATION IN GENETIC ART
The International Glossary on Infertility and Fertility Care, 2017
Dr Ernestine Gwet-Bell
Sherman J. Silber, M.D. Director Infertility Center of St. Louis
Fertility Center HOW MANY DOES IT TAKE? ACHIEVEMENT OF EUPLOID BLASTOCYST (BL) AS THE PRIMARY PREDICTOR OF LIVE BIRTH (LB) IN OOCYTE CRYOPRESERVATION.
Fertility Center Put on ice twice: a problem? Comparison of trophectoderm biopsy (Tebx) with preimplantation genetic screening (pgs) in cycles usiNg previously.
Success Rates Following laboratory advances over the years, including using time-lapse monitoring for all cycles, Galway Fertility Clinic has increased.
Male age negatively impacts embryo development and reproductive outcome in donor oocyte assisted reproductive technology cycles  John L. Frattarelli,
Presentation transcript:

VTF-All /PGS Effect : LBR / cycle / 1st ET BLASTOCYST VITRIFICATION and PREIMPLANTATION GENETIC SCREENING (PGS) HAVE FACILITATED “FREEZE-ALL” CYCLES: A CHANGE IN PRACTICE MANAGEMENT BENEFITING BOTH THE PATIENTS AND LABORATORY #P-643 #P-643 PosterPlus RE Anderson, 1  F Garner, 2  Zozula S,1 JB Whitney, 1 B Shapiro , 2 MC Schiewe​1 1 Ovation Fertility/SCCRM, Newport Beach, CA​; 2 Ovation Fertility/FCLV, Las Vegas, NV Introduction Results Materials & Methods VTF-All /PGS Effect : LBR / cycle / 1st ET PGS Validation (Whitney et al., JARG 2016) Optimization of embryo culture practices led to our highest IVF success rates across all age groups following fresh embryo transfer (ET) in 2010. Live birth rates (LBRs) per ET ranged from 75.3% for donor egg (DE) cycles to 53.2%, 55.1%, 36.8% and 20.7% for women <35 years old, 35-37 years old, 38-40 years old and 41-42 years old, respectively, transferring a mean of 2.0 to 2.6 embryos/ET. In the competitive world of commercial IVF in Southern California, the latter success rates were favorable, ranking in the upper 10th percentile nationally.  However, more than 1/3 of the autologous egg and 3/4 of the donor egg ETs resulted in multiple births in 2010, thus stimulating our lab to adopt the Freeze-All / SET policy we incorporate today. Our routine laboratory procedures include ICSI, group culturing in Global™ medium + 7.5% protein supplement, tri-gas incubation, transvaginal ultrasound guided ET, and vitrification of blastocysts with microSecure (µS-VTF) in non-DMSO I.C.E. solutions (Innovative CryoEnterprises, NJ) at Ovation Fertility Newport Beach or Cryotops with DMSO/EG at Ovation Fertility Las Vegas, with or without blastocyst biopsy (BLBx).  Trends & Discussion Although the mean number of fresh DE embryos transferred decreased from 2.0 to 1.7 between 2010 to 2014, respectively, little change in LBR (55.8% to 56.8%) has occurred. Conversely, a dramatic inverse trend between ET# & % implantation occurred since 2012. The steady adoption of BLBx-PGS using aCGH, in conjunction with vitrification-all/VFET cycles is the key factor, especially evident post-2013. For every 3 live births with fresh autologous transfers in 2015, there were 4 live births with frozen autologous transfers. That is, roughly 21,000 vs 28,000 in total across age groups. That ratio of 1.33 is triple what it was in 2012 (0.44). We expect this rapid trend has continued into 2017, as more programs adopt “freeze-all” cycles. US Centers for Disease Control (CDC), reporting years 2014/2015 SCCRM stats: < 35 yr old 35-37 yr old 38-40 yr old 41-42 yr old Mean # ET      1.1 / 1.0    1.2 / 1.1  1.2 / 1.1    1.1 / 1.1   % Implantation rate 77.9 / 71.3 61.0 / 69.4 60.0 / 71.4 84.0 */ 64.3 % Live birth rate/ET       73.1 / 68.8  66.2 / 65.7 55.0 / 69.1  69.6 / 58.6  % Healthy, term singleton/ET    56.4 / 61.3* 56.3 / 55.7 48.3 / 54.4 69.6 */ 48.3 * Highest nationally reported value that year regardless of age. Objectives 2015, Age <35 = Median values for thawed embryos: 1.5 embryos / 45% IR 2014, Age <35 1.6 embryos / 41% IR 2012, Age <35 1.9 embryos / 28% IR OF-NB affiliates OF-LV affiliate OF-NB Dr. <2015 2013, Age <35 1.8 embryos / 36% IR Conclusions With the implementation of clinical vitrification and progressive adoption of blastocyst biopsy/PGS, we aimed to improve the quality of patient care by routinely transferring single thawed euploid embryos, reducing miscarriages and increasing single, healthy, term live births. ​ Ovation  LOCATIO The global adoption of highly reliable vitrification practices has facilitated significant, progressive improvements in IVF-FET outcomes over time.  In conjunction with blastocyst biopsy/PGS, single euploid embryo transfer (SEET) has optimized embryo utilization rates, and significantly elevated LBRs/cycle in women under 38 years old. Although the same trend was not significant on a per cycle basis in older women (38-42 years old), we have appreciably reduced the trauma/depression associated with pregnancy loss and treatment time interval needed to achieve the desired outcome, “one embryo - one baby”. National average for fresh transfers National average for fresh transfers (national average, fresh) (national average, fresh) Study Design Discussion The annual Assisted Reproductive Technology national reports by the U.S. Centers for Disease Control (CDC) from 2010 to 2015 were used for these analyses.  Our goal was to contrast industry trends regarding fresh DE-ET (control group) to autologous frozen ET cycles, in terms of the number of embryos transferred, implantation rate and LBR/ET, and compare how our clinical practices improved the quality of patient care. While achieving higher success and improved moral standards of patient care with PGS comes at a greater financial cost to the patient and profit to the clinic/lab, laboratories must hire and pay more experienced embryologists to meet the demands of todays’ technology. Unfortunately, an under-supplied workforce of qualified staff may prove to be a limiting factor that requires serious attention. By trusting our vitrification system and BL-Bx technique, we have effectively reduced twinning rates without a decline in implantation success by adopting “freeze-all” cycles with the routine transfer of single euploid blastocysts. Disclosures: JW and REA serve as educators for Illumina. MCS developed mS-VTF without any commercial interests.